Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,300
Closed -$469K 1130
2022
Q4
$469K Sell
4,300
-7,200
-63% -$752K ﹤0.01% 999
2022
Q3
$946K Sell
11,500
-300
-3% -$28.4K ﹤0.01% 870
2022
Q2
$1.1M Sell
11,800
-111,800
-90% -$11.9M ﹤0.01% 867
2022
Q1
$13.8M Sell
123,600
-11,500
-9% -$1.41M 0.04% 420
2021
Q4
$18.4M Buy
135,100
+54,200
+67% +$7.9M 0.05% 383
2021
Q3
$10.8M Buy
80,900
+18,800
+30% +$2.55M 0.03% 477
2021
Q2
$8.74M Sell
62,100
-44,200
-42% -$6.18M 0.02% 548
2021
Q1
$14M Buy
+106,300
New +$13M 0.04% 432
2014
Q4
Sell
-6,505
Closed -$306K 1426
2014
Q3
$306K Hold
6,505
﹤0.01% 1170
2014
Q2
$375K Buy
6,505
+744
+13% +$40.8K ﹤0.01% 1139
2014
Q1
$318K Buy
+5,761
New +$330K ﹤0.01% 1146

Other funds holding EVR

Axa's EVR Position: Q1 2023 in Review

Axa sold out of Evercore (EVR) in Q1 2023, closing a stake of 4,300 shares — an estimated $469K sold.

Axa first reported a position in EVR in Q1 2014 and held it in 11 quarters. The position peaked at $18.4M in Q4 2021. 419 funds tracked by Wall St. Rank hold EVR as of Q1 2023.

  • Axa reported no remaining Evercore position as of Q1 2023 after selling out during the quarter.
  • Axa sold 4,300 Evercore shares in Q1 2023, an estimated $469K.
  • Axa first reported a position in Evercore in Q1 2014 and held it in 11 quarters.
  • Axa's Evercore position peaked at $18.4M in Q4 2021.
  • 419 funds tracked by Wall St. Rank held Evercore as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.